Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Akebia Therapeutics, Inc. (AKBA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/18/2023 |
3
| Snow Ellen (SVP, CFO and Treasurer) has filed a Form 3 on Akebia Therapeutics, Inc. |
| 11/03/2021 |
3
| FRIESON RON (Director) has filed a Form 3 on Akebia Therapeutics, Inc. |
| 02/18/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/28/2021 |
3
| Cotreau Violetta (SVP, Chief Accounting Officer) has filed a Form 3 on Akebia Therapeutics, Inc. |
| 07/02/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/07/2020 |
3
| Wolf Myles (Director) has filed a Form 3 on Akebia Therapeutics, Inc. |
| 08/05/2019 |
3
| Burke Steven Keith (SVP, Chief Medical Officer) has filed a Form 3 on Akebia Therapeutics, Inc. |
| 05/09/2019 |
3
| Faulkingham Dell (CCO) has filed a Form 3 on Akebia Therapeutics, Inc. |
| 12/13/2018 |
3
| Morrison Jodie Pope (Director) has filed a Form 3 on Akebia Therapeutics, Inc. |
| 12/13/2018 |
3
| ROGERS MICHAEL W (Director) has filed a Form 3 on Akebia Therapeutics, Inc. |
| 12/13/2018 |
3
| ADAMS ADRIAN (Director) has filed a Form 3 on Akebia Therapeutics, Inc. |
| 12/13/2018 |
3
| Heffernan Michael Thomas (Director) has filed a Form 3 on Akebia Therapeutics, Inc. |
| 12/13/2018 |
3
| GILMAN STEVEN C (Director) has filed a Form 3 on Akebia Therapeutics, Inc. |
| 12/13/2018 |
3
| Enyedy Mark J (Director) has filed a Form 3 on Akebia Therapeutics, Inc. |
| 08/29/2018 |
3
| Smith Cynthia (Director) has filed a Form 3 on Akebia Therapeutics, Inc. |
| 06/01/2017 |
3
| Jain Rita (SVP, Chief Medical Officer) has filed a Form 3 on Akebia Therapeutics, Inc. |
| 11/23/2016 |
3
| Tubridy Karen L (SVP, Chief Development Officer) has filed a Form 3 on Akebia Therapeutics, Inc. |
| 08/02/2016 |
3
| Canute Scott A (Director) has filed a Form 3 on Akebia Therapeutics, Inc. |
|
|